Copyright Reports & Markets. All rights reserved.

Global Drugs Based on CAR T-cell Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Drugs Based on CAR T-cell by Type
    • 1.3.1 Overview: Global Drugs Based on CAR T-cell Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Drugs Based on CAR T-cell Consumption Value Market Share by Type in 2024
    • 1.3.3 CD19-targeted
    • 1.3.4 BCMA-targeted
  • 1.4 Global Drugs Based on CAR T-cell Market by Application
    • 1.4.1 Overview: Global Drugs Based on CAR T-cell Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Lymphoma
    • 1.4.3 Multiple Myeloma
  • 1.5 Global Drugs Based on CAR T-cell Market Size & Forecast
  • 1.6 Global Drugs Based on CAR T-cell Market Size and Forecast by Region
    • 1.6.1 Global Drugs Based on CAR T-cell Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Drugs Based on CAR T-cell Market Size by Region, (2020-2031)
    • 1.6.3 North America Drugs Based on CAR T-cell Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Drugs Based on CAR T-cell Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Drugs Based on CAR T-cell Market Size and Prospect (2020-2031)
    • 1.6.6 South America Drugs Based on CAR T-cell Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Drugs Based on CAR T-cell Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis Drugs Based on CAR T-cell Product and Solutions
    • 2.1.4 Novartis Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Novartis Recent Developments and Future Plans
  • 2.2 Gilead Sciences
    • 2.2.1 Gilead Sciences Details
    • 2.2.2 Gilead Sciences Major Business
    • 2.2.3 Gilead Sciences Drugs Based on CAR T-cell Product and Solutions
    • 2.2.4 Gilead Sciences Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Gilead Sciences Recent Developments and Future Plans
  • 2.3 Bristol-Myers Squibb
    • 2.3.1 Bristol-Myers Squibb Details
    • 2.3.2 Bristol-Myers Squibb Major Business
    • 2.3.3 Bristol-Myers Squibb Drugs Based on CAR T-cell Product and Solutions
    • 2.3.4 Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.4 J & J
    • 2.4.1 J & J Details
    • 2.4.2 J & J Major Business
    • 2.4.3 J & J Drugs Based on CAR T-cell Product and Solutions
    • 2.4.4 J & J Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 J & J Recent Developments and Future Plans
  • 2.5 JW Therapeutics
    • 2.5.1 JW Therapeutics Details
    • 2.5.2 JW Therapeutics Major Business
    • 2.5.3 JW Therapeutics Drugs Based on CAR T-cell Product and Solutions
    • 2.5.4 JW Therapeutics Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 JW Therapeutics Recent Developments and Future Plans
  • 2.6 FOSUNKite
    • 2.6.1 FOSUNKite Details
    • 2.6.2 FOSUNKite Major Business
    • 2.6.3 FOSUNKite Drugs Based on CAR T-cell Product and Solutions
    • 2.6.4 FOSUNKite Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 FOSUNKite Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Drugs Based on CAR T-cell Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Drugs Based on CAR T-cell by Company Revenue
    • 3.2.2 Top 3 Drugs Based on CAR T-cell Players Market Share in 2024
    • 3.2.3 Top 6 Drugs Based on CAR T-cell Players Market Share in 2024
  • 3.3 Drugs Based on CAR T-cell Market: Overall Company Footprint Analysis
    • 3.3.1 Drugs Based on CAR T-cell Market: Region Footprint
    • 3.3.2 Drugs Based on CAR T-cell Market: Company Product Type Footprint
    • 3.3.3 Drugs Based on CAR T-cell Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Drugs Based on CAR T-cell Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Drugs Based on CAR T-cell Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Drugs Based on CAR T-cell Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Drugs Based on CAR T-cell Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Drugs Based on CAR T-cell Consumption Value by Type (2020-2031)
  • 6.2 North America Drugs Based on CAR T-cell Market Size by Application (2020-2031)
  • 6.3 North America Drugs Based on CAR T-cell Market Size by Country
    • 6.3.1 North America Drugs Based on CAR T-cell Consumption Value by Country (2020-2031)
    • 6.3.2 United States Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Drugs Based on CAR T-cell Consumption Value by Type (2020-2031)
  • 7.2 Europe Drugs Based on CAR T-cell Consumption Value by Application (2020-2031)
  • 7.3 Europe Drugs Based on CAR T-cell Market Size by Country
    • 7.3.1 Europe Drugs Based on CAR T-cell Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 7.3.3 France Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Drugs Based on CAR T-cell Market Size by Region
    • 8.3.1 Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Region (2020-2031)
    • 8.3.2 China Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 8.3.5 India Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Drugs Based on CAR T-cell Consumption Value by Type (2020-2031)
  • 9.2 South America Drugs Based on CAR T-cell Consumption Value by Application (2020-2031)
  • 9.3 South America Drugs Based on CAR T-cell Market Size by Country
    • 9.3.1 South America Drugs Based on CAR T-cell Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Drugs Based on CAR T-cell Market Size by Country
    • 10.3.1 Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Drugs Based on CAR T-cell Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Drugs Based on CAR T-cell Market Drivers
  • 11.2 Drugs Based on CAR T-cell Market Restraints
  • 11.3 Drugs Based on CAR T-cell Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Drugs Based on CAR T-cell Industry Chain
  • 12.2 Drugs Based on CAR T-cell Upstream Analysis
  • 12.3 Drugs Based on CAR T-cell Midstream Analysis
  • 12.4 Drugs Based on CAR T-cell Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Drugs Based on CAR T-cell market size was valued at US$ 5337 million in 2024 and is forecast to a readjusted size of USD 31500 million by 2031 with a CAGR of 29.2% during review period.
    Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
    The CAR T-cell therapy drug gel market is driven by the revolutionary approach of CAR T-cell therapy in cancer treatment and the demand for targeted and personalized therapies. CAR T-cell therapy involves genetically modifying a patient"s own T cells to target and destroy cancer cells. The rise in cancer prevalence and the need for innovative treatments contribute to market growth as healthcare providers seek effective and tailored solutions for patients with difficult-to-treat cancers. Moreover, advancements in gel-based drug delivery systems have improved the precision and safety of CAR T-cell therapy administration. However, the market also faces challenges, including complex manufacturing processes and potential side effects associated with immune response. Additionally, addressing the high cost of CAR T-cell therapies and ensuring scalability and accessibility for broader patient populations can pose obstacles for manufacturers and healthcare systems. To succeed, companies must focus on advancing research and development, collaborating with oncologists to optimize therapy protocols, and addressing the challenges to meet the increasing demand for breakthrough cancer treatments.
    This report is a detailed and comprehensive analysis for global Drugs Based on CAR T-cell market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Drugs Based on CAR T-cell market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Drugs Based on CAR T-cell market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Drugs Based on CAR T-cell market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Drugs Based on CAR T-cell market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Drugs Based on CAR T-cell
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Drugs Based on CAR T-cell market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Drugs Based on CAR T-cell market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    CD19-targeted
    BCMA-targeted
    Market segment by Application
    Lymphoma
    Multiple Myeloma
    Market segment by players, this report covers
    Novartis
    Gilead Sciences
    Bristol-Myers Squibb
    J & J
    JW Therapeutics
    FOSUNKite
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Drugs Based on CAR T-cell product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Drugs Based on CAR T-cell, with revenue, gross margin, and global market share of Drugs Based on CAR T-cell from 2020 to 2025.
    Chapter 3, the Drugs Based on CAR T-cell competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Drugs Based on CAR T-cell market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Drugs Based on CAR T-cell.
    Chapter 13, to describe Drugs Based on CAR T-cell research findings and conclusion.

    Buy now